An overview of progress in the development of Newcastle disease vaccines, from empirical to rational design in modern vaccine development

References

• Abdulhaqq, S. A., and D. B. Weiner. 2008. “DNA Vaccines: Developing New Strategies to Enhance Immune Responses.” Immunologic Research 42 (1–3): 219–232. https://doi.org/10.1007/s12026-008-8076-3.
   PubMed Web of Science ®Google Scholar
• Facciolà, A., G. Visalli, A. Laganà, and A. Di Pietro. 2022. ““An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives.” Vaccines 10 (5): 819. https://doi.org/10.3390/vaccines10050819.
   Web of Science ®Google Scholar
• Bensink, Z., and P. Spradbrow. 1999. “Newcastle Disease Virus Strain I2–A Prospective Thermostable Vaccine for Use in Developing Countries.” Veterinary Microbiology 68 (1–2): 131–139. https://doi.org/10.1016/S0378-1135(99)00069-3.
   PubMed Web of Science ®Google Scholar
• Bernasconi, V., B. Bernocchi, L. Ye, M. Q. Le, A. Omokanye, R. Carpentier, K. Schön, et al. 2018. “Porous Nanoparticles with Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections.” Frontiers in Immunology 9:2060. https://doi.org/10.3389/fimmu.2018.02060.
   PubMed Web of Science ®Google Scholar
• Bournazos, S., T. T. Wang, and J. V. Ravetch. 2016. “The Role and Function of Fcγ Receptors on Myeloid Cells.”In Microbiol Spectr 4 (6): 10.
   Web of Science ®Google Scholar
• Carleton, H. A. 2010. “Pathogenic bacteria as vaccine vectors: teaching old bugs new tricks.” Yale Journal of Biology and Medicine 83 (4): 217–22.
   PubMedGoogle Scholar
• Chen, X., S. Chen, H. Chen, J. Tian, X. Zhao, Y. Jia, S. Xiao, X. Wang, H. Liu, and Z. Yang, 2021. “Comparative Biology of Two Genetically Closely Related Newcastle Disease Virus Strains with Strongly Contrasting Pathogenicity.” Veterinary Microbiology 253:108977. https://doi.org/10.1016/j.vetmic.2020.108977.
   PubMed Web of Science ®Google Scholar
• Conan, A., F. L. Goutard, S. Sorn, and S. Vong. 2012. “Biosecurity Measures for Backyard Poultry in Developing Countries: A Systematic Review.” BMC Veterinary Research 8 (1): 1–10. https://doi.org/10.1186/1746-6148-8-240.
   PubMed Web of Science ®Google Scholar
• Correia, B. E., J. T. Bates, R. J. Loomis, G. Baneyx, C. Carrico, J. G. Jardine, P. Rupert, et al. 2014. “Proof of Principle for Epitope-Focused Vaccine Design.” Nature 507 (7491): 201–206. https://doi.org/10.1038/nature12966.
   PubMed Web of Science ®Google Scholar
• Cui, Z. 2005. “DNA Vaccine.” Advances in Genetics 54:257–289. https://doi.org/10.1016/S0065-2660(05)54011-2.
   PubMed Web of Science ®Google Scholar
• de Vries, E., W. Du, H. Guo, and C. A. M. de Haan. 2020. “Influenza a Virus Hemagglutinin–Neuraminidase–Receptor Balance: Preserving Virus Motility.” Trends in Microbiology 28 (1): 57–67. https://doi.org/10.1016/j.tim.2019.08.010.
   PubMed Web of Science ®Google Scholar
• Dhakal, S., X. Cheng, J. Salcido, S. Renu, K. Bondra, Y. S. Lakshmanappa, C. Misch, et al. 2018. “Liposomal Nanoparticle-Based Conserved Peptide Influenza Vaccine and Monosodium Urate Crystal Adjuvant Elicit Protective Immune Response in Pigs.” International Journal of Nanomedicine 13:6699. https://doi.org/10.2147/IJN.S178809.
   PubMed Web of Science ®Google Scholar
• Dimitrov, K. M., A. M. Ramey, X. Qiu, J. Bahl, and C. L. Afonso. 2016. “Temporal, Geographic, and Host Distribution of Avian Paramyxovirus 1 (Newcastle Disease Virus).” Infection, Genetics and Evolution 39:22–34. https://doi.org/10.1016/j.meegid.2016.01.008.
   PubMed Web of Science ®Google Scholar
• Doria-Rose, N. A., and N. L. Haigwood. 2003. “DNA Vaccine Strategies: Candidates for Immune Modulation and Immunization Regimens.” Methods 31 (3): 207–216. https://doi.org/10.1016/S1046-2023(03)00135-X.
   PubMed Web of Science ®Google Scholar
• Esaki, M., A. Godoy, J. K. Rosenberger, S. C. Rosenberger, Y. Gardin, A. Yasuda, and K. M. Dorsey 2013. “Protection and Antibody Response Caused by Turkey Herpesvirus Vector Newcastle Disease Vaccine.” Avian Diseases 57 (4): 750–755. https://doi.org/10.1637/10540-032613-Reg.1.
   PubMed Web of Science ®Google Scholar
• Ewer, K. J., T. Lambe, C. S. Rollier, A. J. Spencer, A. V. S. Hill, and L. Dorrell. 2016. “Viral Vectors as Vaccine Platforms: From Immunogenicity to Impact.” Current Opinion in Immunology 41:47–54. https://doi.org/10.1016/j.coi.2016.05.014.
   PubMed Web of Science ®Google Scholar
• Firouzamandi, M., H. Moeini, S. D. Hosseini, M. H. Bejo, A. R. Omar, P. Mehrbod, M. E. El Zowalaty, T. J. Webster, and A. Ideris. 2016. “Preparation, Characterization, and in Ovo Vaccination of Dextran-Spermine Nanoparticle DNA Vaccine Coexpressing the Fusion and Hemagglutinin Genes Against Newcastle Disease.” International Journal of Nanomedicine 11:259. https://doi.org/10.2147/IJN.S92225.
   PubMed Web of Science ®Google Scholar
• Firouzamandi, M., H. Moeini, D. Hosseini, M. H. Bejo, A. R. Omar, P. Mehrbod, and A. Ideris 2016. “Improved Immunogenicity of Newcastle Disease Virus Inactivated Vaccine Following DNA Vaccination Using Newcastle Disease Virus Hemagglutinin-Neuraminidase and Fusion Protein Genes.” Journal of Veterinary Science 17 (1): 21–26. https://doi.org/10.4142/jvs.2016.17.1.21.
   PubMed Web of Science ®Google Scholar
• Fukanoki, S., T. Iwakura, S. Iwaki, K. Matsumoto, R. Takeda, K. Ikeda, Z. Shi, et al. 2001. “Safety and Efficacy of Water-In-Oil-In-Water Emulsion Vaccines Containing Newcastle Disease Virus Haemagglutinin-Neuraminidase Glycoprotein.” Avian Pathology 30 (5): 509–516. https://doi.org/10.1080/03079450120078707.
   PubMed Web of Science ®Google Scholar
• Geus, E. D., J. M. J. Rebel, and L. Vervelde. 2012. “Induction of Respiratory Immune Responses in the Chicken; Implications for Development of Mucosal Avian Influenza Virus Vaccines.” Veterinary Quarterly 32 (2): 75–86. https://doi.org/10.1080/01652176.2012.711956.
   PubMed Web of Science ®Google Scholar
• Gimenez, G. G., H. Costa, Q. A. de Lima Neto, M. A. Fernandez, S. A. Ferrarotti, and G. Matioli. 2019. “Sequencing, Cloning, and Heterologous Expression of Cyclomaltodextrin Glucanotransferase of Bacillus Firmus Strain 37 in Bacillus subtilis WB800.” Bioprocess and Biosystems Engineering 42 (4): 621–629. https://doi.org/10.1007/s00449-018-02068-4.
   PubMed Web of Science ®Google Scholar
• Gregorio, E., and R. Rappuoli. 2014. “From Empiricism to Rational Design: A Personal Perspective of the Evolution of Vaccine Development.” Nature Reviews Immunology 14 (7): 505–514. https://doi.org/10.1038/nri3694.
   PubMed Web of Science ®Google Scholar
• Gururaj, K., J. J. Kirubaharan, V. K. Gupta, R. S. Pawaiya, S. Naikawadi, and A. K. Mishra 2014. “Past and Present of Reverse Genetics in Animal Virology with Special Reference to Non–Segmented Negative Stranded RNA Viruses: A Review.” Advances in Animal & Veterinary Sciences 2 (3S): 40–48. https://doi.org/10.14737/journal.aavs/2014/2.3s.40.48.
   Google Scholar
• Hitchner, S. B., G. Reising, and H. Van Roekel. 1951. “Characteristics of the B1 Strain of Newcastle Disease Virus.” American Journal of Veterinary Research 12 (44): 246–249.
   PubMed Web of Science ®Google Scholar
• Huang, Z., A. Panda, S. Elankumaran, D. Govindarajan, D. D. Rockemann, and S. K. Samal. 2004. “The Hemagglutinin-Neuraminidase Protein of Newcastle Disease Virus Determines Tropism and Virulence.” Journal of Virology 78 (8): 4176–4184. https://doi.org/10.1128/JVI.78.8.4176-4184.2004.
   PubMed Web of Science ®Google Scholar
• Jazayeri, S. D., and C. L. Poh. 2019. “Recent Advances in Delivery of Veterinary DNA Vaccines Against Avian Pathogens.” Veterinary Research 50 (1): 78. https://doi.org/10.1186/s13567-019-0698-z.
   PubMed Web of Science ®Google Scholar
• Kanekiyo, M., M. G. Joyce, R. A. Gillespie, J. R. Gallagher, S. F. Andrews, H. M. Yassine, A. K. Wheatley, et al. 2019. “Mosaic Nanoparticle Display of Diverse Influenza Virus Hemagglutinins Elicits Broad B Cell Responses.” Nature Immunology 20 (3): 362–372. https://doi.org/10.1038/s41590-018-0305-x.
   PubMed Web of Science ®Google Scholar
• Kazi, A., C. Chuah, A. B. A. Majeed, C. H. Leow, B. H. Lim, and C. Y. Leow. 2018. “Current Progress of Immunoinformatics Approach Harnessed for Cellular-And Antibody-Dependent Vaccine Design.” Pathogens and Global Health 112 (3): 123–131. https://doi.org/10.1080/20477724.2018.1446773.
   PubMed Web of Science ®Google Scholar
• Khalid, Kanwal, and Chit Laa Poh. 2023. “The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria.“ Vaccines 11 (7): 1264. https://doi.org/10.3390/vaccines11071264.
   Web of Science ®Google Scholar
• Khattar, S. K., Y. Yan, A. Panda, P. L. Collins, and S. K. Samal. 2009. “A Y526Q Mutation in the Newcastle Disease Virus HN Protein Reduces Its Functional Activities and Attenuates Virus Replication and Pathogenicity.” Journal of Virology 83 (15): 7779–7782. https://doi.org/10.1128/JVI.00536-09.
   PubMed Web of Science ®Google Scholar
• Kim, S.-H., S. Xiao, H. Shive, P. L. Collins, S. K. Samal, and B. T. Velayudhan. 2012. “Replication, Neurotropism, and Pathogenicity of Avian Paramyxovirus Serotypes 1–9 in Chickens and Ducks.” PLos One 7 (4): e34927. https://doi.org/10.1371/journal.pone.0034927.
   PubMed Web of Science ®Google Scholar
• Koff, W. C., D. R. Burton, P. R. Johnson, B. D. Walker, C. R. King, G. J. Nabel, R. AhmedM. K. Bhan, and S. A. Plotkin. 2013. “Accelerating Next-Generation Vaccine Development for Global Disease Prevention.” Science (1979) 340 (6136): 1232910. https://doi.org/10.1126/science.1232910.
   PubMed Web of Science ®Google Scholar
• Krause, A., and S. Worgall. 2011. “Delivery of Antigens by Viral Vectors for Vaccination.” Therapeutic Delivery 2 (1): 51–70. https://doi.org/10.4155/tde.10.84.
   PubMedGoogle Scholar
• Kumar, S., B. Nayak, P. L. Collins, and S. K. Samal. 2011. “Evaluation of the Newcastle Disease Virus F and HN Proteins in Protective Immunity by Using a Recombinant Avian Paramyxovirus Type 3 Vector in Chickens.” Journal of Virology 85 (13): 6521–6534. https://doi.org/10.1128/JVI.00367-11.
   PubMed Web of Science ®Google Scholar
• Kushnir, N., S. J. Streatfield, and V. Yusibov. 2012. “Virus-Like Particles as a Highly Efficient Vaccine Platform: Diversity of Targets and Production Systems and Advances in Clinical Development.” Vaccine: X 31 (1): 58–83. https://doi.org/10.1016/j.vaccine.2012.10.083.
   Google Scholar
• Lai, M. D., M. C. Yen, C. M. Lin, C. F. Tu, C. C. Wang, P.-S. Lin, H.-J. Yang, and C.-C. Lin. 2009. “The Effects of DNA Formulation and Administration Route on Cancer Therapeutic Efficacy with Xenogenic EGFR DNA Vaccine in a Lung Cancer Animal Model.” Genetic Vaccines and Therapy 7 (1): 1–13. https://doi.org/10.1186/1479-0556-7-2.
   PubMedGoogle Scholar
• Leigh-Hunt, N., D. Bagguley, K. Bash, V. Turner, S. Turnbull, N. Valtorta, and W. Caan. 2017. “An Overview of Systematic Reviews on the Public Health Consequences of Social Isolation and Loneliness.Public Health.” Public Health 152 (Nov): 157–171. https://doi.org/10.1016/j.puhe.2017.07.035.
   PubMedGoogle Scholar
• Liniger, M., A. Zuniga, and H. Y. Naim. 2007. “Use of Viral Vectors for the Development of Vaccines.” Expert Review of Vaccines 6 (2): 255–266. https://doi.org/10.1586/14760584.6.2.255.
   PubMed Web of Science ®Google Scholar
• Liu, B., Y. Ji, Z. Lin, Y. Fu, R. Muhammad Dafallah, and Q. Zhu. 2015. “Two Single Amino Acid Substitutions in the Intervening Region of Newcastle Disease Virus HN Protein Attenuate Viral Replication and Pathogenicity.” Scientific Reports 5 (1): 1–10. https://doi.org/10.1038/srep13038.
   Google Scholar
• Liu, T., Y. Song, Y. Yang, Y. Bu, J. Cheng, G. Zhang, and J. Xue 2019. “Hemagglutinin–Neuraminidase and Fusion Genes are Determinants of NDV Thermostability.” Veterinary Microbiology 228:53–60. https://doi.org/10.1016/j.vetmic.2018.11.013.
   PubMed Web of Science ®Google Scholar
• Li, Q., W. Wang, G. Hu, X. Cui, D. Sun, Z. Jin, and K. Zhao, 2021. “Evaluation of Chitosan Derivatives Modified Mesoporous Silica Nanoparticles as Delivery Carrier.” Molecules 26 (9): 2490. https://doi.org/10.3390/molecules26092490.
   PubMed Web of Science ®Google Scholar
• Marcink, T. C., E. Yariv, K. Rybkina, V. Más, F. T. Bovier, A. des Georges, A. L. Greninger, et al. 2020. “Hijacking the Fusion Complex of Human Parainfluenza Virus as an Antiviral Strategy.” mBio 11 (1): e03203–19. https://doi.org/10.1128/mBio.03203-19.
   PubMed Web of Science ®Google Scholar
• Mayers, J., K. L. Mansfield, and I. H. Brown. 2017. “The Role of Vaccination in Risk Mitigation and Control of Newcastle Disease in Poultry.” Vaccine: X 35 (44): 5974–5980. https://doi.org/10.1016/j.vaccine.2017.09.008.
   Google Scholar
• Mayr, U. B., P. Walcher, C. Azimpour, E. Riedmann, C. Haller, and W. Lubitz. 2005. “Bacterial Ghosts as Antigen Delivery Vehicles.” Advanced Drug Delivery Reviews 57 (9): 1381–1391. https://doi.org/10.1016/j.addr.2005.01.027.
   PubMed Web of Science ®Google Scholar
• Mezhenskaya, D., I. Isakova-Sivak, and L. Rudenko. 2019. “M2e-Based Universal Influenza Vaccines: A Historical Overview and New Approaches to Development.” Journal of Biomedical Science 26 (1): 1–15. https://doi.org/10.1186/s12929-019-0572-3.
   PubMed Web of Science ®Google Scholar
• Mirza, A. M., and R. M. Iorio. 2013. “A Mutation in the Stalk of the Newcastle Disease Virus Hemagglutinin-Neuraminidase (HN) Protein Prevents Triggering of the F Protein Despite Allowing Efficient HN-F Complex Formation.” Journal of Virology 87 (15): 8813–8815. https://doi.org/10.1128/JVI.01066-13.
   PubMed Web of Science ®Google Scholar
• Moghbeli, M., and R. Dorostkar. 2013. “Construction of Recombinant Bacmid DNA Encoding Newcastle Disease Virus (NDV) Fusion Protein Gene.” Iran Journal of Virology 7 (1): 15–20. https://doi.org/10.21859/isv.7.1.2.15.
   Google Scholar
• Mohsen, M. O., L. Zha, G. Cabral-Miranda, and M. F. Bachmann. 2017. “Major Findings and Recent Advances in Virus–Like Particle (VLP)-Based Vaccines.” Seminars in Immunology Elsevier 34:123–132. https://doi.org/10.1016/j.smim.2017.08.014.
   PubMed Web of Science ®Google Scholar
• Morrison, T. G. 2010. “Newcastle Disease Virus-Like Particles as a Platform for the Development of Vaccines for Human and Agricultural Pathogens.” Future Virology 5 (5): 545–554. https://doi.org/10.2217/fvl.10.50.
   PubMed Web of Science ®Google Scholar
• Muhammad, B., N. A. M. Siti, Y. Khatijah, I. Aini, H.-B. Mohd, P. P. Ben, and R. O. Abdul. 2020. “Development of an Effective and Stable Genotype-Matched Live Attenuated N. Disease Virus Vaccine Based on a Novel Naturally Recombinant M. Isolate Using Reverse Genetics.” Vaccines 8 (2): 270. https://doi.org/10.3390/vaccines8020270.
   Web of Science ®Google Scholar
• Murulitharan, K., K. Yusoff, A. R. Omar, and A. Molouki. 2013. “Characterization of Malaysian Velogenic NDV Strain AF2240-I Genomic Sequence: A Comparative Study.” Virus Genes 46 (3): 431–440. https://doi.org/10.1007/s11262-012-0874-y.
   PubMed Web of Science ®Google Scholar
• Nascimento, I. P., and L. Leite. 2012. “Recombinant Vaccines and the Development of New Vaccine Strategies.” Brazilian Journal of Medical and Biological Research 45 (12): 1102–1111. https://doi.org/10.1590/S0100-879X2012007500142.
   PubMed Web of Science ®Google Scholar
• Palya, V., I. Kiss, T. Tatar-Kis, T. Mato, B. Felföldi, and Y. Gardin. 2012. “Advancement in Vaccination Against Newcastle Disease: Recombinant HVT NDV Provides High Clinical Protection and Reduces Challenge Virus Shedding with the Absence of Vaccine Reactions.” Avian Diseases 56 (2): 282–287. https://doi.org/10.1637/9935-091511-Reg.1.
   PubMed Web of Science ®Google Scholar
• Pantua, H. D., L. W. McGinnes, M. E. Peeples, and T. G. Morrison. 2007. “Requirements for the Assembly and Release of Newcastle Disease Virus-Like Particles.” Journal of Virology 81 (3): 1537. https://doi.org/10.1128/JVI.02532-06.
   Web of Science ®Google Scholar
• Park, J.-K., D.-H. Lee, S.-S. Yuk, E.-O. Tseren-Ochir, J.-H. Kwon, J.-Y. Noh, B.-Y. Kim, et al. 2014. “Virus-Like Particle Vaccine Confers Protection Against a Lethal Newcastle Disease Virus Challenge in Chickens and Allows a Strategy of Differentiating Infected from Vaccinated Animals.” Clinical and Vaccine Immunology 21 (3): 360–365. https://doi.org/10.1128/CVI.00636-13.
   PubMedGoogle Scholar
• Peixoto, C., M. F. Q. Sousa, A. C. Silva, M. J. T. Carrondo, and P. M. Alves. 2007. “Downstream Processing of Triple Layered Rotavirus Like Particles.” Journal of Biotechnology 127 (3): 452–461. https://doi.org/10.1016/j.jbiotec.2006.08.002.
   PubMed Web of Science ®Google Scholar
• Perozo, F., P. Villegas, R. Dolz, C. L. Afonso, and L. B. Purvis. 2008. “The VG/GA Strain of Newcastle Disease Virus: Mucosal Immunity, Protection Against Lethal Challenge and Molecular Analysis.” Avian Pathology 37 (3): 237–245. https://doi.org/10.1080/03079450802043734.
   PubMed Web of Science ®Google Scholar
• Petrovsky, N., and J. C. Aguilar. 2004. “Vaccine Adjuvants: Current State and Future Trends.” Immunology and Cell Biology 82 (5): 488–496. https://doi.org/10.1111/j.0818-9641.2004.01272.x.
   PubMed Web of Science ®Google Scholar
• Pfaller, C. K., R. Cattaneo, and M. J. Schnell. 2015. “Reverse Genetics of Mononegavirales: How They Work, New Vaccines, and New Cancer Therapeutics.” Virology 479:331–344. https://doi.org/10.1016/j.virol.2015.01.029.
   PubMed Web of Science ®Google Scholar
• Pulendran, B., S. P. Arunachalam, and D. T. O’Hagan. 2021. “Emerging Concepts in the Science of Vaccine Adjuvants.” Nature Reviews Drug Discovery 20 (6): 454–475. https://doi.org/10.1038/s41573-021-00163-y.
   PubMed Web of Science ®Google Scholar
• Qi, M., X. Zhang, X. Sun, X. Zhang, Y. Yao, S. Liu, Z. Chen, et al. 2018. “Intranasal Nanovaccine Confers Homo‐And Hetero‐Subtypic Influenza Protection.” Small 14 (13): 1703207. https://doi.org/10.1002/smll.201703207.
   PubMed Web of Science ®Google Scholar
• Ranjbar, M., M. Ebrahimi, S. Shahsavandi, T. Farhadi, A. Mirjalili, M. Tebianian, and M. H. Motedayen. 2019. “Novel Applications of Immuno-Bioinformatics in Vaccine and Bio-Product Developments at Research Institutes.” Archives of Razi Institute 74 (3): 219–233. https://doi.org/10.22092/ari.2018.122523.1224.
   PubMedGoogle Scholar
• Rappuoli, R. 2001. “Reverse Vaccinology, a Genome-Based Approach to Vaccine Development.” Vaccine: X 19 (17–19): 2688–2691. https://doi.org/10.1016/S0264-410X(00)00554-5.
   Google Scholar
• Rauw, F., Y. Gardin, V. Palya, S. Van Borm, M. Gonze, S. Lemaire, T. van den Berg, and B. Lambrecht. 2009. “Humoral, Cell-Mediated and Mucosal Immunity Induced by Oculo-Nasal Vaccination of One-Day-Old SPF and Conventional Layer Chicks with Two Different Live Newcastle Disease Vaccines.” Vaccine: X 27 (27): 3631–3642. https://doi.org/10.1016/j.vaccine.2009.03.068.
   Google Scholar
• Reed, S. G., M. T. Orr, and C. B. Fox. 2013. “Key Roles of Adjuvants in Modern Vaccines.” Nature Medicine 19 (12): 1597–1608. https://doi.org/10.1038/nm.3409.
   PubMed Web of Science ®Google Scholar
• Rehmani, S. F., A. Wajid, T. Bibi, B. Nazir, N. Mukhtar, A. Hussain, N. A. Lone, T. Yaqub, and C. L. Afonso. 2015. “Presence of Virulent Newcastle Disease Virus in Vaccinated Chickens in Farms in Pakistan.” Journal of Clinical Microbiology 53 (5): 1715–1718. https://doi.org/10.1128/JCM.02818-14.
   PubMed Web of Science ®Google Scholar
• Renu, S., N. Feliciano-Ruiz, S. Ghimire, Y. Han, J. Schrock, S. Dhakal, V. Patil, S. Krakowka, and G. J. Renukaradhya. 2020. “Poly (I: C) Augments Inactivated Influenza Virus-Chitosan Nanovaccine Induced Cell Mediated Immune Response in Pigs Vaccinated Intranasally.” Veterinary Microbiology 242:108611. https://doi.org/10.1016/j.vetmic.2020.108611.
   PubMed Web of Science ®Google Scholar
• Roohani, K., S. W. Tan, S. K. Yeap, A. Ideris, M. H. Bejo, and A. R. Omar. 2015. “Characterisation of Genotype VII Newcastle Disease Virus (NDV) Isolated from NDV Vaccinated Chickens, and the Efficacy of LaSota and Recombinant Genotype VII Vaccines Against Challenge with Velogenic NDV.” Journal of Veterinary Science 16 (4): 447–457. https://doi.org/10.4142/jvs.2015.16.4.447.
   PubMed Web of Science ®Google Scholar
• Ross, T. M., K. Mahmood, C. J. Crevar, K. Schneider-Ohrum, P. M. Heaton, and R. A. Bright. 2009. “A Trivalent Virus-Like Particle Vaccine Elicits Protective Immune Responses Against Seasonal Influenza Strains in Mice and Ferrets.” PLoS One 4 (6): e6032. https://doi.org/10.1371/journal.pone.0006032.
   PubMed Web of Science ®Google Scholar
• Ruan, B., X. Zhang, C. Zhang, P. Du, C. Meng, M. Guo, Y. Wu, and Y. Cao. 2020. “Residues 315 and 369 in HN Protein Contribute to the Thermostability of Newcastle Disease Virus.” Frontiers in Microbiology 11:560482. https://doi.org/10.3389/fmicb.2020.560482.
   PubMed Web of Science ®Google Scholar
• Saade, F., and N. Petrovsky. 2012. “Technologies for Enhanced Efficacy of DNA Vaccines.” Expert Review of Vaccines 11 (2): 189–209. https://doi.org/10.1586/erv.11.188.
   PubMed Web of Science ®Google Scholar
• Sadigh-Eteghadi, S., I. Khalili, H. Babaei, R. Toroghi, N. Razmaraii, and L. Froghy. 2012. “Immunogenicity of Commercial, Formaldehyde and Binary Ethylenimine Inactivated Newcastle Disease Virus Vaccines in Specific Pathogen Free Chickens.”Archives of Razi Institue 67 (1): 21–25. https://doi.org/10.22092/ARI.2016.103883.
   Google Scholar
• Sallusto, F., and A. Lanzavecchia. 2000. “Understanding Dendritic Cell and T-Lymphocyte Traffic Through the Analysis of Chemokine Receptor Expression.” Immunological Reviews 177 (1): 134–140. https://doi.org/10.1034/j.1600-065X.2000.17717.x.
   PubMedGoogle Scholar
• Sawant, P. M., P. C. Verma, P. K. Subudhi, U. Chaturvedi, M. Singh, R. Kumar, and A. K. Tiwari. 2011. “Immunomodulation of Bivalent Newcastle Disease DNA Vaccine Induced Immune Response by Co-Delivery of Chicken IFN-γ and IL-4 Genes.” Veterinary Immunology and Immunopathology 144 (1–2): 36–44. https://doi.org/10.1016/j.vetimm.2011.07.006.
   PubMed Web of Science ®Google Scholar
• Senne, D. A., D. J. King, and D. R. Kapczynskio. 2004. “Control of Newcastle Disease by Vaccination.” Developments in Biologicals 119:165–170.
   PubMedGoogle Scholar
• Shafaati, M., M. Ebadi, and M. Ghorbani. 2022. “A Short Review of Progress in Development of Newcastle Disease Vaccines.” Journal of Veterinary Medicine and Research 9 (2): 1231. https://doi.org/10.47739/2378-931X/1231.
   Google Scholar
• Shafaati, M., M. Ghorbani, M. Mahmodi, M. Ebadi, and R. Jalalirad. 2022a. “Molecular Evaluation and Genetic Characterisation of Newcastle Disease Virus’s Haemagglutinin‐Neuraminidase Protein Isolated from Broiler Chickens in Iran.” Veterinary Medicine and Science 8 (1): 219–228. https://doi.org/10.1002/vms3.629.
   PubMed Web of Science ®Google Scholar
• Shafaati, M., M. Ghorbani, M. Mahmoodi, M. Ebadi, and R. Jalalirad. 2022b. “Expression and Characterization of Hemagglutinin–Neuraminidase Protein from Newcastle Disease Virus in Bacillus subtilis WB800.” Journal of Genetic Engineering & Biotechnology 20 (1): 1–13. https://doi.org/10.1186/s43141-022-00357-w.
   PubMed Web of Science ®Google Scholar
• Shin, J., and V. Noireaux. 2010. “Efficient Cell-Free Expression with the Endogenous E. Coli RNA Polymerase and Sigma Factor 70.” Journal of Biological Engineering 4 (1): 8–9. https://doi.org/10.1186/1754-1611-4-8.
   PubMedGoogle Scholar
• Skenderi, F., and S. Jonjić. 2012. “Viral Vaccines and Vectors–Some Lessons from Cytomegaloviruses.” Periodicum Biologorum 114 (2): 201–210.
   Web of Science ®Google Scholar
• Soleymani, S., A. Tavassoli, and M. R. Housaindokht. 2022. “An Overview of Progress from Empirical to Rational Design in Modern Vaccine Development, with an Emphasis on Computational Tools and Immunoinformatics Approaches.” Computers in Biology and Medicine 140:105057. https://doi.org/10.1016/j.compbiomed.2021.105057.
   PubMed Web of Science ®Google Scholar
• Song, J.-M., B.-Z. Wang, K.-M. Park, N. Van Rooijen, F.-S. Quan, M.-C. Kim, H.-T. Jin, A. Pekosz, R. W. Compans, and S.-M. Kang. 2011. “Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity.” PLoS One 6 (1): e14538. https://doi.org/10.1371/journal.pone.0014538.
   PubMed Web of Science ®Google Scholar
• Stear, M. J. 2005. “OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (Mammals, Birds and Bees) 5th Edn. Volumes 1 & 2. World Organization for Animal Health 2004. ISBN 92 9044 622 6. €140.” Parasitology 130 (6): 727. https://doi.org/10.1017/S0031182005007699.
   Google Scholar
• Stobart, C. C., and M. L. Moore. 2014. “RNA Virus Reverse Genetics and Vaccine Design.” Viruses 6 (7): 2531–2550. https://doi.org/10.3390/v6072531.
   PubMed Web of Science ®Google Scholar
• Sunita, S. A., Y. Singh, and P. Shukla. 2020. “Computational Tools for Modern Vaccine Development.” Human Vaccines & Immunotherapeutics 16 (3): 723–735. https://doi.org/10.1080/21645515.2019.1670035.
   PubMed Web of Science ®Google Scholar
• Sun, H.-L., Y.-F. Wang, D. Y. Miao, P.-J. Zhang, H.-D. Zhi, L. Xu, M. Wang, G. Tong, and M. Wang. 2006. “Construction and Characterization of Recombinant Fowlpox Virus Co-Expressing F and HN Genes of Newcastle Disease Virus and gB Gene of Infectious Larygnotracheitis Virus.” Chinese Journal of Biotechnology 22 (6): 931–938. https://doi.org/10.1016/S1872-2075(06)60066-6.
   Google Scholar
• Tlaxca, J. L., S. Ellis, and R. L. Remmele, Jr. 2015. “Live Attenuated and Inactivated Viral Vaccine Formulation and Nasal Delivery: Potential and Challenges.” Advanced Drug Delivery Reviews 93:56–78. https://doi.org/10.1016/j.addr.2014.10.002.
   PubMed Web of Science ®Google Scholar
• Toussi, D. N., and P. Massari. 2014. “Immune Adjuvant Effect of Molecularly-Defined Toll-Like Receptor Ligands.” Vaccines (Basel) 2 (2): 323–353. https://doi.org/10.3390/vaccines2020323.
   PubMedGoogle Scholar
• Uddowla, S., L. C. Freytag, and J. D. Clements. 2007. “Effect of Adjuvants and Route of Immunizations on the Immune Response to Recombinant Plague Antigens.” Vaccine: X 25 (47): 7984–7993. https://doi.org/10.1016/j.vaccine.2007.09.030.
   Google Scholar
• Vasou, A., N. Sultanoglu, S. Goodbourn, R. E. Randall, and L. G. Kostrikis. 2017. “Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses.” Viruses 9 (7): 186. https://doi.org/10.3390/v9070186.
   PubMed Web of Science ®Google Scholar
• Vicente, T., A. Roldão, C. Peixoto, M. J. T. Carrondo, and P. M. Alves. 2011. “Large-Scale Production and Purification of VLP-Based Vaccines.” Journal of Invertebrate Pathology 107:S42–S48. https://doi.org/10.1016/j.jip.2011.05.004.
   PubMed Web of Science ®Google Scholar
• Vickers, N. J. 2017. “Animal Communication: When I’m Calling You, Will You Answer Too?” Current Biology 27 (14): R713–R715. https://doi.org/10.1016/j.cub.2017.05.064.
   PubMed Web of Science ®Google Scholar
• Wang, J., P. Li, Y. Yu, Y. Fu, H. Jiang, M. Lu, Z. Sun, S. Jiang, L. Lu, and M. X. Wu. 2020. “Pulmonary Surfactant–Biomimetic Nanoparticles Potentiate Heterosubtypic Influenza Immunity.” Science (1979) 367 (6480): eaau0810. https://doi.org/10.1126/science.aau0810.
   PubMed Web of Science ®Google Scholar
• Weli, S. C., and M. Tryland. 2011. “Avipoxviruses: Infection Biology and their Use as Vaccine Vectors.” Virology Journal 8 (1): 1–15. https://doi.org/10.1186/1743-422X-8-49.
   PubMedGoogle Scholar
• Williams, J. A. 2014. “Improving DNA Vaccine Performance Through Vector Design.” Current Gene Therapy 14 (3): 170–189. https://doi.org/10.2174/156652321403140819122538.
   PubMed Web of Science ®Google Scholar
• Winterfield, R. W., A. S. Dhillon, and L. J. Alby. 1980. “Vaccination of Chickens Against Newcastle Disease with Live and Inactivated Newcastle Disease Virus.” Poultry Science 59 (2): 240–246. https://doi.org/10.3382/ps.0590240.
   PubMed Web of Science ®Google Scholar
• Win, S. J., V. K. Ward, P. R. Dunbar, S. L. Young, and M. A. Baird. 2011. “Cross‐Presentation of Epitopes on Virus‐Like Particles via the MHC I Receptor Recycling Pathway.” Immunology and Cell Biology 89 (6): 681–688. https://doi.org/10.1038/icb.2010.161.
   PubMed Web of Science ®Google Scholar
• Xiao, S., B. Nayak, A. Samuel, A. Paldurai, M. Kanabagattebasavarajappa, T. Y. Prajitno, E. E. Bharoto, P. L. Collins, and S. K. Samal. 2012. “Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain.” PLoS One 7 (12): e52751. https://doi.org/10.1371/journal.pone.0052751.
   PubMed Web of Science ®Google Scholar
• Yan, C., H. Liu, Y. Jia, D.-W. Prince-Theodore, M. Yang, F. E. Addoma Adam, J. Ren, et al. 2020. “Screening and Mechanistic Study of Key Sites of the Hemagglutinin-Neuraminidase Protein Related to the Virulence of Newcastle Disease Virus.” Poultry Science 99 (7): 3374–3384. https://doi.org/10.1016/j.psj.2020.04.014.
   PubMed Web of Science ®Google Scholar
• Yuan, P., T. B. Thompson, B. A. Wurzburg, R. G. Paterson, R. A. Lamb, and T. S. Jardetzky. 2005. “Structural Studies of the Parainfluenza Virus 5 Hemagglutinin-Neuraminidase Tetramer in Complex with Its Receptor, Sialyllactose.” Structure 13 (5): 803–815. https://doi.org/10.1016/j.str.2005.02.019.
   PubMed Web of Science ®Google Scholar
• Zabel, F., T. M. Kündig, and M. F. Bachmann. 2013. “Virus-Induced Humoral Immunity: On How B Cell Responses are Initiated.” Current Opinion in Virology 3 (3): 357–362. https://doi.org/10.1016/j.coviro.2013.05.004.
   PubMed Web of Science ®Google Scholar
• Zhai, L., Y. Li, W. Wang, and S. Hu. 2011. “Enhancement of Humoral Immune Responses to Inactivated Newcastle Disease and Avian Influenza Vaccines by Oral Administration of Ginseng Stem-And-Leaf Saponins in Chickens.” Poultry Science 90 (9): 1955–1959. https://doi.org/10.3382/ps.2011-01433.
   PubMed Web of Science ®Google Scholar
• Zhao, K., X. Duan, L. Hao, X. Wang, and Y. Wang. 2017. “Immune Effect of Newcastle Disease Virus DNA Vaccine with C3d as a Molecular Adjuvant.” Journal of Microbiology and Biotechnology 27 (11): 2060–2069. https://doi.org/10.4014/jmb.1708.08017.
   PubMed Web of Science ®Google Scholar
• Zhao, K., J. Han, Y. Zhang, L. Wei, S. Yu, X. Wang, Z. Jin, and Y. Wang. 2018. “Enhancing Mucosal Immune Response of Newcastle Disease Virus DNA Vaccine Using N-2-hydroxypropyl Trimethylammonium Chloride Chitosan and N, O-Carboxymethyl Chitosan Nanoparticles as Delivery Carrier.” Molecular Pharmaceutics 15 (1): 226–237. https://doi.org/10.1021/acs.molpharmaceut.7b00826.
   PubMed Web of Science ®Google Scholar
• Zhao, L., A. Seth, N. Wibowo, C.-X. Zhao, N. Mitter, C. Yu, and A. P. J. Middelberg. 2014. “Nanoparticle Vaccines.” Vaccine: X 32 (3): 327–337. https://doi.org/10.1016/j.vaccine.2013.11.069.
   Google Scholar
• Zhao, K., Y. Zhang, X. Zhang, W. Li, C. Shi, C. Guo, C. Dai, et al. 2014. “Preparation and Efficacy of Newcastle Disease Virus DNA Vaccine Encapsulated in Chitosan Nanoparticles.” International Journal of Nanomedicine 9:389. https://doi.org/10.2147/IJN.S54226.
   PubMed Web of Science ®Google Scholar